| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |